Mishcon de Reya has advised AI-driven continuous care platform Mirae on its $5.4 million funding round, led by Oxford Science Enterprises.
Mirae is a University of Oxford spinout built on computational health research from the University’s Computational Health Informatics Lab. The company was founded by CEO Anuj Patel, James Nishiyama Finucane and Professor David Clifton, whose research in disease progression modelling provides the algorithmic foundation for Mirae’s technology.
Mishcon de Reya is seeing continued momentum in Oxford’s buoyant technology market, advising on several recent funding rounds. The combination of rich scientific talent alongside best-in-class class science facilities means Oxford remains a global hub for innovation attracting investment to support the world changing technologies that emerge from the eco system.
The funding will support the launch and continued development of Mirae’s platform as the company seeks to improve access to consistent, data-driven care for people living with complex chronic conditions.
Anuj Patel, co-founder and CEO of Mirae, commented: “Where you live should not dictate the quality of care you receive. A lot of the variability in care and outcomes comes from the fact that clinicians are working without a full view of what has happened between visits. When you combine experiential data with clinical data, you begin to understand and model disease more effectively and have a path towards true precision medicine.”
Nicola McConville, Partner at Mishcon de Reya, said: “We are so pleased to have supported Anuj, David and the wider Mirae team on this funding round. Mirae is applying outstanding Oxford research to a deep challenge in chronic care: giving clinicians a fuller and more continuous picture of each patient’s experience. We look forward to seeing the team use this investment to develop and scale its platform, with the potential to improve outcomes for patients living with complex chronic conditions.”